Hypofractionated radiotherapy for organ-confined prostate cancer: is less more? - Wikidata - wikimedia - TriplyDB

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

http://www.wikidata.org/entity/Q38863898

about

Enhanced DNA Damages of Human Prostate Cancer Cells Induced by Radiofrequency Capacitive Hyperthermia Pre- and Post X-rays: 6 MV versus 15 MV.Smart Radiation Therapy Biomaterials.Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer.

P2860

Q33738054-D5C8ABBC-CDF9-4950-824C-41E15FD45F82 Q39105322-DA2A5B32-B534-440E-9E75-89D692F08BF6 Q40421115-D7DE8040-7F67-40FA-9760-416F3E7288B8 Q48187227-271407CC-F324-40C8-821E-10FF23EC7A31

P2860

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

http://www.wikidata.org/entity/Q38863898

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

@en

type

label

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

@en

prefLabel

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

@en

P1433

Q38863898-BA2A9143-E6D2-4351-90A8-AD59A47B091A

P1476

Q38863898-405070CF-3A2F-42DE-BF14-44B88D43C78D

P2093

Q38863898-BE71FEF8-A84E-41C0-9400-CA201DA55DC6

Q38863898-CC60DFC3-CD85-468D-9653-30C9F71AA8CF

P2860

Q38863898-048569B1-9B29-495D-9A5F-23D26003AC7D

Q38863898-11837226-2DBE-468E-BC42-8CFB61138230

Q38863898-12F4AB1F-76CA-47AC-ADE7-BD3D2B999BB5

Q38863898-157F49C7-D8AC-45C0-8245-7D46116CB572

Q38863898-16C3158D-36C7-4E93-A89F-1584FCB949B8

Q38863898-246EA54E-3377-4C7A-BB47-261A2B6638D4

Q38863898-2ABAAD2C-ED0F-4596-916A-C5925C9BD1F2

Q38863898-346E6B78-9FAA-4483-A809-1868DEAE4B77

Q38863898-374275E4-F109-447A-951A-6F6935FD90AC

Q38863898-3D7E37BB-F44F-44AC-848F-8114389F21DC

P2888

Q38863898-9DEDA3DD-7C4E-4855-B32A-5F95488586C5

P304

Q38863898-138BAF5E-36BF-44CB-903A-22141188D752

P31

Q38863898-9EABC3E0-19EE-491A-A64D-52655A6EACC0

P356

Q38863898-F820E190-9438-49E2-81F3-F16AAD52F456

P407

Q38863898-49A451F4-B6D2-4EFE-B3E8-1ECE3B138C34

P433

Q38863898-91212DD1-0E6C-432F-B359-A1A36474CA57

P478

Q38863898-8AED5FC5-8563-4356-B678-80306004027E

P577

Q38863898-A7B083A2-D03A-4CAA-8B4D-72BB38E3BC35

P6179

Q38863898-47A0B342-1438-406B-9149-CC6078FA2D9A

P698

Q38863898-0B5A6001-867E-4935-9CB8-3E43F75D89C5

P356

NRUROL.2016.106

P1433

Nature Reviews Urology

P1476

Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

@en

P2093

Carlo Greco

http://www.w3.org/2001/XMLSchema#string

Stefano Arcangeli

http://www.w3.org/2001/XMLSchema#string

P2860

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Annual patient time costs associated with medical care among cancer survivors in the United States

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results

Innovations in image-guided radiotherapy.

A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer.

P2888

nrurol.2016.106

P304

400-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRUROL.2016.106

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006172381

http://www.w3.org/2001/XMLSchema#string

P698

27296648

http://www.w3.org/2001/XMLSchema#string